Psychiatry - Neuro/Psych Pharmacol News & Articles

661 Could treatment of iron deficiency both improve ADHD and reduce cardiovascular risk during treatment with ADHD drugs Medical Hypotheses, June 7, 2012    Clinical Article

662 Adaptive Behavior Outcomes in Infants Treated With Adjunctive Topiramate Pediatric Neurology , June 7, 2012    Clinical Article

663 Escitalopram-induced word finding difficulty General Hospital Psychiatry, June 7, 2012

664 Role of aripiprazole in treatment-resistant schizophrenia Full Text Neuropsychiatric Disease and Treatment, June 6, 2012    Clinical Article

665 Combination Treatment With Aripiprazole and Valproic Acid for Acute Mania: An 8-Week, Single-Blind, Randomized Controlled Trial Clinical Neuropharmacology, June 6, 2012    Clinical Article

666 Chronic renal failure in lithium-using geriatric patients: effects of lithium continuation versus discontinuation--a 60-month retrospective study International Journal of Geriatric Psychiatry, June 6, 2012    Clinical Article

667 Effects of polypharmacy on sleep in psychiatric inpatients Schizophrenia Research, June 6, 2012    Clinical Article

668 Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial International Clinical Psychopharmacology, June 5, 2012    Clinical Article

669 A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder International Clinical Psychopharmacology, June 5, 2012    Clinical Article

670 Lu AA21004, a multimodal psychotropic agent, in the prevention of relapse in adult patients with generalized anxiety disorder International Clinical Psychopharmacology, June 5, 2012    Clinical Article

671 Sertindole in the long-term treatment of schizophrenia International Clinical Psychopharmacology, June 4, 2012    Clinical Article

672 Time to all-cause treatment discontinuation of olanzapine compared to other antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis European Neuropsychopharmacology, June 4, 2012    Evidence Based Medicine    Clinical Article

673 An open-label pilot study of aripiprazole for male and female Veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants International Clinical Psychopharmacology, June 4, 2012    Clinical Article

674 Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians perceptions of adherence vs. pharmacy claims International Journal of Clinical Practice, June 1, 2012    Clinical Article

675 Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data Full Text BMC Psychiatry, June 1, 2012    Clinical Article

676 Understanding How Data Triangulation Identifies Acute Toxicity of Novel Psychoactive Drugs Journal of Medical Toxicology, June 1, 2012

677 Road traffic crashes and prescribed methadone and buprenorphine: A french registry-based case-control study Drug and Alcohol Dependence, May 31, 2012    Clinical Article

678 Glutamatergic Effects of Divalproex in Adolescents With Mania: A Proton Magnetic Resonance Spectroscopy Study Journal of the American Academy of Child & Adolescent Psychiatry, May 30, 2012    Clinical Article

679 Celecoxib or Naproxen Treatment Does Not Benefit Depressive Symptoms in Persons Age 70 and Older: Findings From a Randomized Controlled Trial The American Journal of Geriatric Psychiatry, May 30, 2012    Clinical Article

680 Methylphenidate in Children With ADHD With or Without Learning Disability Journal of Attention Disorders, May 30, 2012    Clinical Article

1 Nidotherapy for people with schizophrenia Cochrane Reviews, April 11, 2013    Evidence Based Medicine

2 Augmentation with Atypical Antipsychotics for Depression: A Review of Evidence-Based Support from the Medical Literature Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, March 13, 2013    Evidence Based Medicine

3 Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophrenia International Clinical Psychopharmacology, April 25, 2013

4 Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study Neuropsychiatric Disease and Treatment, April 18, 2013    Free full text

5 Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study Schizophrenia Research, April 16, 2013

6 A randomized add-on trial of high-dose d -cycloserine for treatment-resistant depression International Journal of Neuropsychopharmacology, March 6, 2013

7 Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies Journal of Psychopharmacology, April 8, 2013

8 The sertraline versus electrical current therapy for treating depression clinical study (SELECT-TDCS): results of the crossover and follow-up phases Depression and Anxiety, April 29, 2013

9 Add-on fluvoxamine treatment for schizophrenia: an updated meta-analysis of randomized controlled trials European Archives of Psychiatry and Clinical Neuroscience, April 22, 2013    Evidence Based Medicine

10 A Randomized Trial on the Acute and Steady-State Effects of a New Antidepressant, Vortioxetine, on Actual Driving and Cognition Clinical Pharmacology & Therapeutics, April 24, 2013

11 Guidance for the Discontinuation or Switching of Antidepressant Therapies in Adults Journal of Pharmacy Practice, March 26, 2013    Clinical Guideline

12 The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial Schizophrenia Research, April 17, 2013

13 A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence European Neuropsychopharmacology, April 12, 2013

14 Reboxetine Treatment for Autistic Spectrum Disorder of Pediatric Patients With Depressive and Inattentive/Hyperactive Symptoms: An Open-Label Trial Clinical Neuropharmacology, April 5, 2013

15 Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression Human Psychopharmacology: Clinical and Experimental, March 28, 2013

16 Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only Journal of Psychiatric Research, April 15, 2013

17 Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial International Journal of Neuropsychopharmacology, April 2, 2013
Exclusive Author Commentary

18 Asenapine effects on individual Young Mania Rating Scale items in bipolar disorder patients with acute manic or mixed episodes: a pooled analysis Neuropsychiatric Disease and Treatment, April 9, 2013    Free full text

19 The Fetal Safety of Fluoxetine: A Systematic Review and Meta-Analysis Journal of Obstetrics and Gynaecology Canada, April 11, 2013    Free full text    Evidence Based Medicine    Review Article

20 A double-blind, placebo-controlled study of adjunctive calcitonin nasal spray in acute refractory mania Bipolar Disorders, April 2, 2013